New antihypertensive drug to be covered by health insurance as new substance
Published: 2006-06-22 06:58:00
Updated: 2006-06-22 06:58:00
Recently, the Health Insurance Review Agency approved a local pharmaceutical company's antihypertensive drug as a new substance and the market for antihypertension medicines dominated by a multinational giant is expected to enter fierce competition.
We have acknowledged the Ahngook Pharm's le...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
